Home MDWD
loading
Calls Options of MDWD for (Expired in 13 days)
Strike Price Change % Change Volume
favorite 2.50 0.05 0.00 0.00% 0
favorite 5.00 0.17 0.00 0.00% 0
favorite 7.50 0.00 0.00 0.00% 0
Puts Options of MDWD for (Expired in 13 days)
Strike Price Change % Change Volume
favorite
2.50
0.00 0.00 0.00% 0
favorite
5.00
0.00 0.00 0.00% 0
favorite
7.50
0.00 0.00 0.00% 0
MediWound Ltd., an integrated biopharmaceutical company, focuses on developing, manufacturing, and commercializing novel therapeutics products to address unmet needs. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns in the European Union, Israel, and Argentina. The company also develops EscharEx, which is in Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.
Cap:    |  Volume (24h):